ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02573324
Brief Title: A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification ( Intellance1 ) (Intellance1)

First Submitted : September 28, 2015
First Submitted that Met QC Criteria : October 8, 2015
First Posted : October 9, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : June 19, 2018
Last Update Posted : June 21, 2018 (Estimate)